Faucette; Ryan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Faucette; Ryan.The latest application filed is for "assays for determining plasma kallikrein system biomarkers".

Company Profile

5.9.16

Faucette; Ryan - Melrose MA
Faucette; Ryan - Arlington MA
Faucette; Ryan - Somerville MA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Assays For Determining Plasma Kallikrein System Biomarkers App 20220291232 - Sexton; Daniel J. ; et al.	2022-09-15
Assays for determining plasma kallikrein system biomarkers Grant 11,372,002 - Sexton , et al. June 28, 2	2022-06-28
Evaluation And Treatment Of Bradykinin-mediated Disorders App 20220170936 - Sexton; Daniel J. ; et al.	2022-06-02
Metabolite biomarkers for diseases associated with the contact activation system Grant 11,340,237 - Sexton , et al. May 24, 2	2022-05-24
Methods of determining levels of cleaved and/or intact kininogen Grant 11,156,612 - Sexton , et al. October 26, 2	2021-10-26
Evacuated Blood Collection Tubes Containing Protease Inhibitors For The Assessment Of Contact System Activation App 20210322972 - Sexton; Daniel J. ; et al.	2021-10-21
Protein Biomarkers For Diseases Associated With The Contact Activation System App 20210285962 - Sexton; Daniel J. ; et al.	2021-09-16
Immunoassay To Detect Cleaved High Molecular Weight Kininogen App 20210270842 - Sexton; Daniel J. ; et al.	2021-09-02
Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema Grant 11,084,884 - Sexton , et al. August 10, 2	2021-08-10
Plasma Kallikrein Binding Proteins And Uses Thereof In Treating Hereditary Angioedema App 20210087293 - Sexton; Daniel J. ; et al.	2021-03-25
Immunoassay to detect cleaved high molecular weight kininogen Grant 10,914,747 - Sexton , et al. February 9, 2	2021-02-09
Peptide Quantitation Assay For Differentiating Full-length High Molecular Weight Kininogen (hmwk) And Cleaved Hmwk App 20210025898 - Wu; Jiang ; et al.	2021-01-28
Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation Grant 10,870,115 - Sexton , et al. December 22, 2	2020-12-22
Metabolite Biomarkers For Diseases Associated With The Contact Activation System App 20190361036 - Sexton; Daniel J. ; et al.	2019-11-28
Rna Biomarkers For Hereditary Angioedema App 20190241961 - Sexton; Daniel J. ; et al.	2019-08-08
Evacuated Blood Collection Tubes Containing Protease Inhibitors For The Assessment Of Contact System Activation App 20190022641 - Sexton; Daniel J. ; et al.	2019-01-24
Immunoassay To Detect Cleaved High Molecular Weight Kininogen App 20180306807 - Sexton; Daniel J. ; et al.	2018-10-25
Plasma Kallikrein Binding Proteins And Uses Thereof In Treating Hereditary Angioedema App 20170002094 - Sexton; Daniel J. ; et al.	2017-01-05
Assays For Determining Plasma Kallikrein System Biomarkers App 20160252527 - Sexton; Daniel J. ; et al.	2016-09-01
Evaluation And Treatment Of Bradykinin-mediated Disorders App 20150362493 - Sexton; Daniel J. ; et al.	2015-12-17
Methods for reducing the mitogenicity of lectin compositions Grant 8,729,242 - Lancaster , et al. May 20, 2	2014-05-20
Methods For Reducing The Mitogenicity Of Lectin Compositions App 20100130726 - LANCASTER; Thomas M. ; et al.	2010-05-27
Methods for reducing the mitogenicity of lectin compositions Grant 7,687,608 - Lancaster , et al. March 30, 2	2010-03-30
Methods for reducing the mitogenicity of lectin compositions App 20070110811 - Lancaster; Thomas M. ; et al.	2007-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.